Tom C. Thomas - 15 Feb 2023 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Reporting relationship: Officer
Issuer ticker: VINC
Reported as of: 15 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Feb 2023, 15:05:35 UTC
Prior SEC filing: 14 Dec 2022
Next SEC filing: 10 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Tom C. Thomas

Key filing fact

Tom C. Thomas filed Form 4 for Vincerx Pharma, Inc. (VINC) on 16 Feb 2023.

Key facts

This page summarizes Tom C. Thomas's Form 4 filing for Vincerx Pharma, Inc. (VINC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Feb 2023, 15:05.

Change

Previous filing in this sequence was filed on 14 Dec 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +86,000
Change %
Price: $0.000000
Shares after: 86,000
Date: 15 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 86,000
Exercise price: $1.17
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option vests in twenty-four equal monthly installments starting from February 15, 2023.

SEC remarks

General Counsel and Chief Legal Officer Represents the 3rd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.